HELIXPAN, the broadest view
Cancer drivers across tissues: for histories that span more than one organ, for survivors of cancers the organ applications do not cover, and for anyone who wants the most complete picture. It complements the screenings recommended for you; it never replaces them.
HELIXPAN in full, on bioinst.com
HELIXGUT, the digestive tract
For people followed for a digestive condition, such as reflux and Barrett’s oesophagus, removed polyps, pancreatic cysts or fatty liver, or after a digestive cancer. It follows the digestive drivers in your blood between one scope and the next, alongside your gastroenterologist’s plan.
HELIXGUT in full, on bioinst.com
HELIXLUNG, the lungs
After lung cancer, with a nodule under follow-up, or with a smoking or exposure history: it follows the lung drivers in your blood between one CT scan and the next. It replaces none of your scans or oncology appointments.
HELIXLUNG in full, on bioinst.com
HELIXGYN, breast and gynecologic
For women after breast or ovarian cancer, with a known hereditary variant, dense breasts or a lesion under surveillance. It complements your mammograms, MRI and follow-up with a reading of acquired changes over time. It is not a BRCA or hereditary test.
HELIXGYN in full, on bioinst.com
What every application has in common
- A Bioscience Institute physician reviews your health questionnaire and prescribes the test if it is right for you.
- You draw the sample at home with the kit we ship overnight, or at a partner location; the analysis is done in a CLIA/CAP-certified laboratory.
- Your report arrives within 8 weeks, and physicians and genomic counselors walk you through it.
- Your first test sets your reference. The tests that follow show whether the changes hold steady, build, or build faster, and your physician decides when you test again.
Read how the program works and what a Cancer Driver Condition is.
Availability
HELIXAFE is available in the United States from 16 October 2026, through helixafe.bioinst.com. Each application is described in full, in four languages, on bioinst.com.
Opening in the United States
Be first to hear when HELIXAFE opens
Register for the waitlist. About one email a week, only about the science.
Join the US waitlistEducational content. Not a substitute for medical advice. HELIXAFE does not diagnose, treat, predict or prevent disease and does not replace recommended cancer screenings.
Last updated
